Orphan Therapeutics, LLC is a privately held drug development company. It was founded in 2003 with the purpose to develop and seek regulatory approval for terlipressin for the treatment of Hepatorenal Syndrome (HRS) type 1 primarily in the US.
Also known as: Orphan Therapeutics, LLC
  • 0
  • 0
Interest Score
4
HIT Score
0.82
Founder

President
Domain
orphantherapeutics.com

Actual
www.orphantherapeutics.com

IP
44.194.54.221

Status
OK

Category
Company
0 comments Add a comment